Free Trial
OTCMKTS:CNTMF

Cansortium Full Year Earnings Report

Cansortium logo
$0.02 +0.00 (+3.85%)
As of 10:50 AM Eastern

Cansortium EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$0.14

Cansortium Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cansortium Announcement Details

Quarter
Full Year
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cansortium Earnings Headlines

FLUENT Provides Management Update
FLUENT Reports First Quarter 2026 Results
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does. But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight.tc pixel
Vireo Growth to Acquire FLUENT in All-Stock Transaction
FLUENT Reports Fourth Quarter and Full Year 2025 Results
See More Cansortium Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cansortium? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cansortium and other key companies, straight to your email.

About Cansortium

Cansortium (OTCMKTS:CNTMF), Inc. (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets. The company has invested in high-intensity cultivation infrastructure and advanced manufacturing processes to ensure product consistency and supply reliability. Leadership is headed by CEO Daniel O’Connell, who has overseen the company’s growth strategy and digital retail initiatives.

View Cansortium Profile